AllPennyStocks.com SLS Stock Holds Steady After Q2 Update — Investors Eye End Of GPS Quiet Period
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

SLS Stock Holds Steady After Q2 Update — Investors Eye End Of GPS Quiet Period

The biotech, focused on novel cancer therapies, reported a net loss of $9.6 million, or $0.05 per share, for the quarter ended June 30.

Other Penny Stock Movers

Casino Tables Are Going Social, and This Microcap Just Expanded Its Reach
This Mining Tech Play Wants to Turn Stranded Deposits Into Metal
Curaleaf Eyes Aurora Cannabis in Deal That Could Reshape the Global Cannabis Market
Most Popular
{{ index + 1 }}


Back to Top